HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Davide Gabbieri Pascal M. Dohmen Wolfgang Konertz Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gabbieri, D. Articles by Konertz, W. Search for Related Content PubMed PubMed Citation Articles by Gabbieri, D. Articles by Konertz, W. Related Collections Great vessels Valve disease

J Thorac Cardiovasc Surg 2007;133:1088-1089
© 2007 The American Association for Thoracic Surgery

Brief Communication

Ross procedure with a tissue-engineered heart valve in complex congenital aortic valve disease

^a Department of Cardiovascular Surgery, Charité Hospital, Medical University Berlin, Germany
^b Department of Radiology, Charité Hospital, Medical University Berlin, Germany
^c Department of Anesthesiology, Charité Hospital, Medical University Berlin, Germany.

Received for publication December 6, 2006; accepted for publication December 12, 2006.

^_* Address for reprints: Davide Gabbieri, MD, Department of Cardiovascular Surgery, Charité Hospital, Medicine University Berlin, Charitéplatz 1, D-10117 Berlin, Germany. (Email: dgabbieri@yahoo.it).

The first 20% of the full text of this article appears below.

The Ross procedure achieved an established position in the treatment of congenital aortic valve disease.¹ However, right ventricular outflow tract (RVOT) reconstruction still limits this procedure. We describe a patient with recurrent aortic valve stenosis after repeated surgical and interventional procedures. The Ross operation was performed, and the RVOT was reconstructed using a tissue-engineered (TE) heart valve.

Clinical Summary

A 23-year-old woman with congenital bicuspid aortic valve stenosis was referred to our department for recurrence of left ventricular–aortic pressure gradient after multiple surgical and interventional procedures at other hospitals. Chronologically, the patient underwent closure of the patent ductus arteriosus at birth, resection of a subaortic membrane and open valvotomy 5 years later, closure of iatrogenic ventricular septal defect during the next year, and new open valvotomy with closure of the residual ventricular septal defect at the age of 14 years. The following year a percutaneous balloon aortic valvotomy was performed. After the . . . [Full Text of this Article]

This article has been cited by other articles:

				J. E. Jordan, J. K. Williams, S.-J. Lee, D. Raghavan, A. Atala, and J. J. Yoo Bioengineered self-seeding heart valves J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 201 - 208. [Abstract] [Full Text] [PDF]